U.S. Markets close in 2 hrs 26 mins

JNJ’s OTC, Oral Care, and Wound Care Businesses: Key Trends in Q1

Margaret Patrick
JNJ’s OTC, Oral Care, and Wound Care Businesses: Key Trends in Q1

Is Johnson & Johnson an Attractive Buy following Its Q1 Results?(Continued from Prior Part)OTC businessIn the first quarter, Johnson & Johnson’s (JNJ) OTC (over-the-counter) business reported revenue of $1.09 billion, reflecting YoY